Bellerophon Therapeutics (BLPH) Reports Q3 Loss of $0.37/Share

Bellerophon Therapeutics (NASDAQ: BLPH) reported Q3 EPS of ($0.37), versus ($0.83) reported last year.

For earnings history and earnings-related data on Bellerophon Therapeutics (BLPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Keurig Dr Pepper coffee chief to depart ahead of planned split
• MP Materials seen largely insulated after China export-control move